Narrow-band imaging versus Lugol chromoendoscopy for esophageal squamous cell cancer screening in normal endoscopic practice: randomized controlled trialM Gruner, Mathieu Pioche, Angélique Denis et al.|Endoscopy|2020Cited by 64
Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)Debora Basile, M. Svrcek, François Ghiringhelli et al.|Annals of Oncology|2022Cited by 44
Narrow-Band Imaging (NBI) versus coloration Lugol dans la détection du carcinome de l'oesophage dans une population à haut risque: un essai contrôlé randomisé multicentrique en situation de vraie vieM Grüner, T Ponchon, Mathieu Pioche et al.|Endoscopy|2018Cited by 0
NARROW-BAND IMAGING (NBI) VERSUS LUGOL CHROMOENDOSCOPY IN THE DETECTION OF OESOPHAGUS SQUAMOUS NEOPLASMS IN A HIGH-RISK POPULATION: A REAL-LIFE RANDOMISED CONTROLLED MULTICENTRE TRIALM Gruner, Mathieu Pioche, A. Denis et al.|Endoscopy|2018Cited by 0
388MO Tumor budding, an important prognostic factor in stage III colon cancer patients treated with oxaliplatin-based chemotherapyDebora Basile, Magali Svrcek, Chloé Broudin et al.|Annals of Oncology|2021Cited by 0